Random Transgenic

CETP Random Transgenic Mouse Model
EZcohort™ Models
The easiest way to acquire and breed cryopreserved GEMs

  • Model #
  • Genotype
  • Nomenclature
  • 3715-F
    B6.SJL-Tg(APOA-CETP)1Dsg N11
  • 3715-M
    B6.SJL-Tg(APOA-CETP)1Dsg N11
  • Contains human cholesteryl ester transfer protein transgene
  • Exhibits dramatic reduction in serum HDL cholesterol
  • Useful for identifying and evaluating compounds that increase HDL cholesterol levels and for atherosclerosis studies
  • Differs from model 1003 in that it has been backcrossed for six additional generations to C57BL/6, thereby reducing genes from the SJL strain
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.

Genetic Background:

B6.SJL Background


The CETP mouse was developed in the laboratory of Dr. David Grass at Xenogen Biosciences, now Taconic. The model was created by microinjecting the human CETP gene into (C57BL/6J x SJL) F2 zygotes. Taconic received stock in April 1996 at the second backcross from the founder line. The mice were then backcrossed one generation to C57BL/6 prior to intercrossing for homozygosity. Backcrossing to C57BL/6NTac recommenced at Taconic in 2004. The line was backcrossed a total of 10 generations (N10) and then intercrossed to homozygosity. A homozygous colony is maintained for the production of hemizygotes through mating to C57BL/6NTac (N11).


Wild type for Nnt mutation





Initial Publication:

Grass, D.S., Saini, U., Felkner, R.H., Wallace, R.E., Lago, W.J.P., Young, S.G., Swanson, M.E. (1995). Transgenic Mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans. The Journal of Lipid Research, Vol. 36, No. 5, pp. 1082-1090.

Conditions of Use for EZcohort™ Models
EZcohort™ models are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic Biosciences, Inc. (Taconic) sells EZcohort™ models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased EZcohort™ models in consideration of purchasers' acknowledgement of and agreement to Taconic's Terms and Conditions for the Sale of Products and the following conditions of use:

  • Title to EZcohort™ models and biological materials derived from them remains with Taconic.
  • EZcohort™ models will be used for research purposes only.
  • EZcohort™ models and biological materials derived from them will not be distributed to third parties or used for commercial purposes.
  • Breeders from deliverables can be used for propagation of EZcohort™ models or to cross to other strains.
  • Continuation of breeding and crossbreeding of EZcohort™ models outside Taconicis permitted for a term of three years post-purchase of the EZcohort™ models and is subject to annual confirmation of these EZcohort™ Conditions of Use.

Continuation of breeding and crossbreeding after the three year term will require renewal of the EZcohort™ Conditions of Use and payment of a fee.